CARDIOME PHARMA CORP's ticker is CRME and the CUSIP is 14159U301. A total of 26 filers reported holding CARDIOME PHARMA CORP in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $16,000 | -98.8% | 10,625 | -98.2% | 0.01% | -98.5% |
| Q3 2017 | $1,285,000 | -55.1% | 600,625 | -5.1% | 0.34% | -55.7% |
| Q2 2017 | $2,860,000 | +73.0% | 632,739 | +14.9% | 0.77% | +85.1% |
| Q1 2017 | $1,653,000 | +8.7% | 550,712 | -0.0% | 0.42% | -1.4% |
| Q4 2016 | $1,521,000 | -16.6% | 550,965 | -5.2% | 0.42% | -29.5% |
| Q3 2016 | $1,824,000 | -38.7% | 580,965 | +0.1% | 0.60% | -45.4% |
| Q2 2016 | $2,977,000 | +37.5% | 580,365 | +9.6% | 1.10% | +23.4% |
| Q1 2016 | $2,165,000 | -54.5% | 529,465 | -9.7% | 0.89% | -47.6% |
| Q4 2015 | $4,756,000 | -2.3% | 586,455 | +1.7% | 1.70% | -17.9% |
| Q3 2015 | $4,866,000 | -2.7% | 576,468 | +8.5% | 2.07% | +17.6% |
| Q2 2015 | $5,002,000 | – | 531,493 | – | 1.76% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,918,722 | $6,006,000 | 4.90% |
| Tamarack Advisers, LP | 4,400,000 | $13,882,000 | 2.18% |
| AlphaOne Investment Services, LLC | 580,965 | $1,824,000 | 0.60% |
| CLOUGH CAPITAL PARTNERS L P | 3,061,064 | $9,581,000 | 0.50% |
| Rock Springs Capital Management LP | 1,200,000 | $3,751,000 | 0.24% |
| TURNER INVESTMENTS LLC | 150,000 | $470,000 | 0.16% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 5,397,007 | $16,893,000 | 0.14% |
| SABBY MANAGEMENT, LLC | 484,505 | $1,521,000 | 0.06% |
| PUTNAM INVESTMENTS LLC | 3,673,622 | $11,536,000 | 0.03% |
| ARDSLEY ADVISORY PARTNERS LP | 28,900 | $90,000 | 0.01% |